DEPO-MEDROL (methylprednisolone acetate)
GLUCOCORTICOSTEROIDS·TRICHINOSIS·+43
A-S MEDICATION
Indication
Angioedema
Angioedema is a clinical condition characterized by abrupt, circumscribed, non-pitting swelling of the deep dermis, subcutaneous tissues, or submucosal layers. Read more about Angioedema
277 drugs 143 manufacturers
Drugs that treat it
Common Angioedema therapies.
DEXAMETHASONE
GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+61
A-S MEDICATION
DEXAMETHASONE SODIUM PHOSPHATE
GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+60
A-S MEDICATION
KENALOG-40 (triamcinolone acetonide)
GLUCOCORTICOSTEROIDS·TRICHINOSIS·+53
A-S MEDICATION
MEDROL (methylprednisolone)
GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+55
A-S MEDICATION
METHYLPREDNISOLONE
GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+55
A-S MEDICATION
METHYLPREDNISOLONE ACETATE
GLUCOCORTICOSTEROIDS·TRICHINOSIS·+43
A-S MEDICATION
PREDNISOLONE
GLUCOCORTICOSTEROIDS·TRICHINOSIS·+59
A-S MEDICATION
PREDNISOLONE SODIUM PHOSPHATE
GLUCOCORTICOSTEROIDS·TRICHINOSIS·+59
A-S MEDICATION
Filter & compare in the drug finder →Opens the drug finder with Angioedema preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAngioedema is a clinical condition characterized by abrupt, circumscribed, non-pitting swelling of the deep dermis, subcutaneous tissues, or submucosal layers.
It frequently affects areas with loose connective tissue, including the face, lips, tongue, extremities, genitalia, and the gastrointestinal or upper respiratory tracts, posing a critical risk of asphyxiation when laryngeal tissues are involved.
Pathophysiologically, it results from transient vascular hyperpermeability driven primarily by the release of vasoactive mediators, most commonly histamine in mast-cell-mediated allergic reactions or bradykinin in hereditary, acquired, or drug-induced forms.
- nih.gov
Angioedema is a clinical condition characterized by abrupt, circumscribed, non-pitting swelling of the deep dermis, subcutaneous tissues, or submucosal layers It frequently affects areas with loose connective tissue, including the face, lips, tongue, extremities, genitalia, and the gastrointestinal or upper respiratory tracts, posing a critical risk of asphyxiation when laryngeal tissues are involved
- nih.gov
Angioedema is a clinical condition characterized by abrupt, circumscribed, non-pitting swelling of the deep dermis, subcutaneous tissues, or submucosal layers
- nih.gov
It frequently affects areas with loose connective tissue, including the face, lips, tongue, extremities, genitalia, and the gastrointestinal or upper respiratory tracts, posing a critical risk of asphyxiation when laryngeal tissues are involved
- medlineplus.gov
It frequently affects areas with loose connective tissue, including the face, lips, tongue, extremities, genitalia, and the gastrointestinal or upper respiratory tracts, posing a critical risk of asphyxiation when laryngeal tissues are involved
- medlineplus.gov
Pathophysiologically, it results from transient vascular hyperpermeability driven primarily by the release of vasoactive mediators, most commonly histamine in mast-cell-mediated allergic reactions or bradykinin in hereditary, acquired, or drug-induced forms
- nih.gov
Pathophysiologically, it results from transient vascular hyperpermeability driven primarily by the release of vasoactive mediators, most commonly histamine in mast-cell-mediated allergic reactions or bradykinin in hereditary, acquired, or drug-induced forms
Personalize your experience
Follow Angioedema and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.